首页> 外国专利> NUCLEIC ACID CODING SEQUENCE FOR TUMOUR REJECTION ANTIGEN PRESENTED BY HUMAN LEUKOCYTE ANTIGEN A2 MOLECULES, VECTORS, HOST CELLS AND TREATMENT AND DIAGNOSIS INVOLVING THE ANTIGEN

NUCLEIC ACID CODING SEQUENCE FOR TUMOUR REJECTION ANTIGEN PRESENTED BY HUMAN LEUKOCYTE ANTIGEN A2 MOLECULES, VECTORS, HOST CELLS AND TREATMENT AND DIAGNOSIS INVOLVING THE ANTIGEN

机译：人白细胞抗原A2分子，载体，宿主细胞表达的肿瘤排斥抗原的核酸编码序列及涉及该抗原的治疗和诊断

页面导航

摘要
著录项
相似文献

摘要

The invention relates to nucleic acid molecules coding for a tumor rejection antigen precursor. Specifically, the tumor rejection antigen precursor, or "TRAP", is processed into at least one tumor rejection antigen, which is presented by HLA-A2 molecules. Ramifications of the discovery are also set forth.

机译：本发明涉及编码肿瘤排斥抗原前体的核酸分子。具体而言，将肿瘤排斥抗原前体或“ TRAP”加工成至少一种由HLA-A2分子呈递的肿瘤排斥抗原。还提出了发现的后果。

著录项

公开/公告号NZ263348A

专利类型
公开/公告日1996-06-25

原文格式PDF
申请/专利权人 LUDWIG INSTITUTE FOR CANCER RESEARCH;
展开▼

申请/专利号NZ19940263348
发明设计人 BRICHARD VINCENT;VAN PEL ALINE;TRAVERSARI CATIA;WOLFEL THOMAS;BOON-FALLEUR THIERRY;DE PLAEN ETIENNE;
展开▼

申请日1994-03-09
分类号C07H21/00;C07H21/04;C12N15/12;C12N15/63;C12N5/10;A61K39/00;G01N33/53;A61K38/18;
国家 NZ
入库时间 2022-08-22 03:53:04

相似文献

专利
外文文献
中文文献